HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John Langenfeld Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Langenfeld, E. M. Articles by Langenfeld, J. Search for Related Content PubMed PubMed Citation Articles by Langenfeld, E. M. Articles by Langenfeld, J. Related Collections Lung - cancer

Ann Thorac Surg 2005;80:1028-1032
© 2005 The Society of Thoracic Surgeons

---

Original article: General thoracic

Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas

^a Department of Surgery, Division of Surgical Sciences, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey
^b Department of Surgery, Division of Thoracic Surgery, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey

Accepted for publication March 23, 2005.

^_* Address reprint requests to Dr Langenfeld, Division of Thoracic Surgery, UMDNJ-Robert Wood Johnson Medical School, MEB 534, One Robert Wood Johnson Place, PO Box 19, New Brunswick, NJ08903-0019. (Email: langenje{at}umdnj.edu).

BACKGROUND: The bone morphogenetic proteins (BMP) are phytogenetically conserved proteins, which are essential for embryonic development. Bone morphogenetic protein-2 (BMP-2) was recently shown to be expressed in a small sample of lung carcinomas. Studies have suggested that BMP-2 may enhance tumor growth. The present study examined which BMP family members are expressed in non-small cell lung carcinomas (NSCLC). Furthermore, the frequency of BMP-2 overexpression and the types of lung carcinomas expressing BMP-2 were determined.

METHODS: Tissue samples were obtained from the operating room and frozen in liquid nitrogen. Samples included metastatic NSCLC, benign lung tumors, adenocarcinoma, squamous cell carcinoma, bronchioloalveolar, and neuroendocrine carcinomas. Paired normal lung tissues served as the controls. The BMP-2, BMP-4, BMP-6, BMP-7, and growth differentiation factor 5 (GDF-5) expressions were examined by Western blot analysis.

RESULTS: The BMP-4, BMP-6, BMP-7, and GDF-5 were infrequently expressed in NSCLC. The BMP-2 was expressed in 41 of 42 NSCLC with minimal expression in normal lung tissue; BMP-2 was expressed 17 fold higher than that of normal lung tissue. The BMP-2 was over-expressed in all subtypes of NSCLC, including neuroendocrine carcinomas. The BMP-2 expression was similar between squamous cell carcinomas and adenocarcinomas; however, bronchioloalveolar carcinomas tended to have a lower level of expression. The BMP-2 was not significantly expressed in benign lung tumors.

CONCLUSIONS: Bone morphogenetic protein-2 is the predominant family member expressed in NSCLC. The BMP-2 is overexpressed in the majority of human lung carcinomas independent of cell type.

This article has been cited by other articles:

				E. M. Langenfeld, Y. Kong, and J. Langenfeld Bone Morphogenetic Protein-2-Induced Transformation Involves the Activation of Mammalian Target of Rapamycin Mol. Cancer Res., December 1, 2005; 3(12): 679 - 684. [Abstract] [Full Text] [PDF]

				A. Iyoda Invited commentary Ann. Thorac. Surg., September 1, 2005; 80(3): 1032 - 1032. [Full Text] [PDF]